Protagenic Therapeutics, Inc. (PTIX)
NASDAQ: PTIX · Real-Time Price · USD
1.670
-0.010 (-0.60%)
At close: Dec 5, 2025, 4:00 PM EST
1.651
-0.019 (-1.15%)
After-hours: Dec 5, 2025, 6:19 PM EST
Protagenic Therapeutics Market Cap
Protagenic Therapeutics has a market cap or net worth of $3.23 million as of December 5, 2025.
Market Cap
3.23M
Enterprise Value
4.53M
1-Year Change
n/a
Ranking
Category
Stock Price
$1.67
Market Cap Chart
Since May 19, 2025, Protagenic Therapeutics's market cap has decreased from $9.64M to $3.23M, a decrease of -66.48%. That is a compound annual growth rate of -86.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 3.25M | -66.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |